Medical Radiation Shielding Market

Medical Radiation Shielding Market Size and Forecast

The global Medical Radiation Shielding Market is valued at USD 1.6 Billion in 2024 and is projected to reach a value of USD 3.27 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.7% between 2025 and 2035.

Medical Radiation Shielding Market Key Highlights

• Based on the Product Type, the X-ray Shields category accounted for significant market share of 51.5% in Medical Radiation Shielding market industry in 2024
• In 2024, by Material, Lead-based Shielding dominated the Medical Radiation Shielding market with significant Medical Radiation Shielding market share of 53.2%
• By Application, Diagnostics dominated the Medical Radiation Shielding market with market share of 51.5% in 2024
• In 2024, by End-use, Hospitals & Clinics dominated the Medical Radiation Shielding market with Medical Radiation Shielding market share of 54.5%
• North America dominated the Medical Radiation Shielding market industry with 36.5% Medical Radiation Shielding market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period in Medical Radiation Shielding market industry

Medical Radiation Shielding Market Growth Factor

Rising Utilization of Nuclear Medicine and Radiation Therapy

The growing use of nuclear medicine and radiotherapy for diagnosing and treating cancer is significantly driving the demand for Medical Radiation Shielding Market. With cancer cases projected to increase to approximately 30 million by 2040, the need for radiation-based treatments is set to rise. Developing regions such as Africa, Asia, and Central & South America account for over 60% of new cancer cases and 70% of global cancer deaths, highlighting the critical role of radiation therapy in these areas. According to the World Nuclear Association, over 40 million nuclear medicine procedures are performed annually, with radioisotope demand increasing by 5% per year. Currently, nearly 10,000 hospitals worldwide utilize radioisotopes, and in the U.S. alone, more than 20 million nuclear medicine procedures are conducted each year. North America dominates the Medical Radiation Shielding market, accounting for 50% of the global share, followed by Europe at 20%. Similarly, radiography (X-ray) remains the most commonly performed imaging test, with 22.9 million procedures recorded by NHS England (2020), followed by ultrasonography (9.51 million), CT scans (5.15 million), and MRI scans (3.46 million). With the increasing reliance on radiation therapy, the demand for Medical Radiation Shielding market is expected to expand significantly.

Medical Radiation Shielding Market Restraint Factor

Limited Healthcare Infrastructure in Emerging Markets

The lack of sufficient healthcare infrastructure, especially in developing and underdeveloped nations restraints the Medical Radiation Shielding market. The high cost and space requirements of radiotherapy devices limit their installation in many regions with constrained healthcare budgets. Despite the increasing demand for cancer treatment, only a small percentage of healthcare facilities in lower-income countries can afford radiation shielding solutions. According to the National Association for Proton Therapy, over 300,000–600,000 patients will receive proton therapy. However, only 1% of radiation therapy patients currently receive proton therapy, due to limited availability and high costs. While high-income countries maintain an average of one radiotherapy unit per 250,000 people, translating to four radiotherapy machines per million population, this ratio is significantly lower in developing nations, restricting access to advanced radiation treatments.

Medical Radiation Shielding Market Opportunity Factor

Growing Healthcare Expenditure in Emerging Economies

Rising healthcare investments in developing countries such as China, India, Brazil, and Mexico are improving access to quality medical services, thereby fueling demand for Medical Radiation Shielding market. The increasing incidence of cancer in these regions is further accelerating the adoption of oncology-related technologies. A surge in per-capita healthcare spending is also driving demand for cost-effective healthcare solutions, including radiation shielding for diagnostic and therapeutic applications. For instance, India’s public healthcare expenditure rose to 2.1% of GDP in 2024–22, up from 1.8% in 2020–21 and 1.3% in 2019–20. Meanwhile, China’s healthcare spending surged by 12.6% to USD 930 billion, with increased government investment in the sector. Additionally, the rapid growth of medical tourism is bolstering healthcare advancements in emerging markets. Countries such as Malaysia and India are becoming leading medical tourism hubs, offering high-quality yet affordable treatments. Malaysia’s medical tourism sector has consistently grown 16–17% year-on-year, surpassing the global average of 10–12% (Medical Tourism Malaysia). India ranks among the top destinations for medical value tourism, with over 56 million inbound trips generating USD 16.3 billion in revenue. It is also the third-largest wellness-focused market in the Asia-Pacific region. With large patient populations, minimal competition, and untapped potential in emerging economies, medical radiation shielding manufacturers have a significant opportunity to expand and capture growth in Medical Radiation Shielding markets.

Product Type Insights

​The Product Type segment is divided into X-ray Shields, MRI Shields, Gamma Shields, Neutron Shields. The X-ray Shields segment held the dominant share in 2024, accounting for significant Medical Radiation Shielding market share of 51.5%.

• X-ray Shields held the most market share in 2024 in Medical Radiation Shielding market as they are essential for radiation protection in medical imaging. The increasing use of diagnostic imaging procedures, particularly X-rays, has driven the demand for effective shielding solutions in healthcare environments. Additionally, advancements in materials science and manufacturing technologies have resulted in more efficient, durable, and user-friendly X-ray shielding products. Growing awareness among healthcare providers and patients regarding the health risks of ionizing radiation has further boosted the adoption of reliable radiation protection solutions across medical facilities.
• The MRI shielding segment is anticipated to witness significant growth in Medical Radiation Shielding market in the coming years, driven by the rising demand for advanced MRI technologies in healthcare institutions worldwide. This segment includes Radiofrequency (RF) shielding systems and magnetic shielding solutions, which are crucial for maintaining a controlled environment and preventing electromagnetic interference (EMI) in MRI imaging. Industry players are actively investing in R&D to enhance MRI shielding technologies. For example, in November 2023, ETS-Lindgren, a leader in EMC and RF testing solutions, showcased cutting-edge MRI shielding advancements at the Healthcare Design (HCD) Expo & Conference in New Orleans, Louisiana. By focusing on technological innovation, companies like ETS-Lindgren are addressing the evolving needs of the healthcare sector, ensuring higher imaging accuracy and improved patient safety.

Material Insights

The Material segment is divided into Lead-based Shielding, Non-lead Shielding, Hybrid Shielding. In 2024, the Lead-based Shielding segment held largest share of 53.2% in the Medical Radiation Shielding market.

• In 2024, the Lead-based Shielding segment held the largest share of the Medical Radiation Shielding market revenue because lead remains the gold standard in radiation shielding due to its high density and excellent attenuation properties, effectively blocking X-rays and gamma rays. Its long-standing use in medical imaging, radiation therapy, industrial radiography, nuclear power plants, and research laboratories underscores its proven reliability. The widespread adoption of X-rays, CT scans, and radiation therapy devices in healthcare settings continues to drive demand for lead shielding solutions as an essential protective measure.
• The non-lead shielding segment is projected to experience the highest growth rate in the coming years in Medical Radiation Shielding market. This shift is fueled by growing concerns over lead toxicity and its environmental impact. Governments and healthcare institutions are actively promoting lead-free alternatives to reduce occupational exposure risks and simplify waste management and disposal. Innovative materials like tungsten and tantalum-based composites are emerging as viable substitutes, offering effective radiation protection without the health and environmental drawbacks associated with traditional lead-based solutions.

Application Insights

The Application segment is divided into Diagnostics, Therapeutics and Nuclear Medicine. In 2024, the Diagnostics segment held largest share of 51.5% in the Medical Radiation Shielding market.

• In 2024, the Diagnostics segment held largest share in the Medical Radiation Shielding market. This segment encompasses radiography (X-ray), CT scans, fluoroscopy, mammography, and dental imaging, because all of which are essential for early disease detection and monitoring. The rising prevalence of chronic illnesses such as cancer and cardiovascular diseases, along with the aging global population, is driving increased demand for diagnostic imaging. According to the United Nations, the proportion of people aged 65 and above is expected to grow from 10% in 2022 to 16% by 2050, further fueling the need for advanced imaging solutions to manage age-related health concerns. Additionally, the growing adoption of 3D mammography, PET/CT, and high-field MRI systems (such as 3T MRI) continues to enhance diagnostic precision and efficiency.
• The therapeutics segment is projected to experience substantial growth in the Medical Radiation Shielding market, driven by the increasing use of radiotherapy, brachytherapy, and proton therapy. These techniques allow for precise tumor targeting, minimizing damage to healthy tissues and improving patient outcomes. The integration of artificial intelligence (AI) and machine learning in radiation therapy planning has further enhanced treatment accuracy and efficiency. A notable advancement in the field was Elekta’s launch of Esprit in May 2022, an innovative radiosurgery system designed to enhance radiotherapy treatment standards. These technological advancements continue to shape the future of cancer treatment and radiation-based therapies.

End-use Insights

The End-use segment is divided into Hospitals & Clinics, Diagnostic Imaging Centers, Radiotherapy Centers, Research Laboratories & Academic Institutions, Other End-use. In 2024, the Hospitals & Clinics segment held largest share of 54.5% in the Medical Radiation Shielding market.

• In 2024, hospitals and clinics accounted for the largest market share in Medical Radiation Shielding market driven by their high demand for radiation protection solutions. These facilities are subject to strict radiation safety regulations, requiring comprehensive shielding measures to ensure the safety of patients, healthcare professionals, and visitors. Additionally, increasing global healthcare expenditure has led to the expansion of hospital infrastructure and the integration of advanced diagnostic imaging equipment, further boosting the Medical Radiation Shielding market solutions.
• The diagnostic imaging centers segment is expected to witness substantial growth in Medical Radiation Shielding market during forecast period. These facilities are increasingly adopting advanced imaging technologies, including MRI, PET-CT, and nuclear medicine scans, all of which require specialized radiation shielding solutions to meet safety standards. Additionally, the growing focus on early disease detection and preventive healthcare has led to an expansion of screening services, increasing the number of diagnostic centers. Many healthcare providers outsource imaging services to standalone diagnostic facilities due to their cost-effectiveness and efficiency, further driving demand for Medical Radiation Shielding market.

Regional Trends

In 2024, the North America captured 36.5% of the revenue share inMedical Radiation Shielding market.

North America Medical Radiation Shielding Market Trends

North America Medical Radiation Shielding market is driven by the increasing adoption of advanced cancer treatments and the rising prevalence of chronic diseases. The U.S., in particular, has witnessed a surge in nuclear medicine procedures, with approximately 20 million procedures conducted annually, according to the Society of Nuclear Medicine. Additionally, Canada has emerged as a leader in nuclear imaging technology, leveraging its expertise in cardiology, oncology, neurology, and other medical specialties to strengthen Medical Radiation Shielding market growth.

The U.S. Medical Radiation Shielding market is growing supported by robust R&D activities in medical devices and biotechnology. Increasing hospital infrastructure investments and government initiatives to enhance radiation safety awareness have further propelled market expansion. The country's advanced healthcare system, along with a high adoption rate of diagnostic and therapeutic procedures, continues to drive Medical Radiation Shielding market solutions.

Asia Pacific Medical Radiation Shielding Market Trends

Asia Pacific region is experiencing the fastest growth in Medical Radiation Shielding market. The Medical Radiation Shielding market expansion is primarily fueled by the rapid expansion is primarily attributed to the rising prevalence of chronic diseases, particularly cancer. According to the National Institutes of Health (NIH), India is expected to see a 12.8% increase in cancer cases by 2025 compared to 2020. Additionally, governments in China and India are heavily investing in healthcare infrastructure and actively promoting the adoption of radiation-based therapies, further accelerating demand for Medical Radiation Shielding market solutions in the region.

Europe Medical Radiation Shielding Market Trends

Europe Medical Radiation Shielding market is witnessing significant growth, largely propelled by the presence of leading industry players and strategic investments in innovation. Research and development efforts in radiation protection technologies are gaining momentum, particularly with initiatives led by the European Alliance for Medical Radiation Protection Research (EURAMED). Programs such as the European Diagnostic Reference Level (DRL) surveys and the establishment of clinical DRLs for radiation safety are strengthening the region’s commitment to enhancing patient protection and optimizing Medical Radiation Shielding market solutions.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Medical Radiation Shielding Market Trends

• Shift Towards Lead-Free Shielding Materials – Growing environmental and health concerns have led to increased adoption of alternative materials such as tungsten, bismuth, and boron-filled polyethylene, reducing reliance on traditional lead-based shielding
• Rising Demand for Radiation Therapy & Diagnostic Imaging – The increasing prevalence of cancer and the expanding use of radiotherapy, MRI, CT scans, and PET imaging have driven the demand for effective radiation shielding in hospitals and diagnostic centers
• Growth of Theranostics & Personalized Medicine – The emergence of theranostics, which combines diagnostic imaging with targeted radiotherapy, is influencing the development of specialized shielding solutions for nuclear medicine and radiopharmaceutical applications
• Expansion of Proton Therapy Centers – Investments in advanced radiation therapy facilities, such as Canada’s first proton therapy center, indicate a growing need for high-energy particle shielding solutions tailored for these cutting-edge treatments
• Regulatory & Safety Compliance Driving Innovation – Stringent regulations from bodies like the FDA and IAEA are pushing manufacturers to develop shielding materials that comply with safety standards while offering better protection and cost efficiency
• Advancements in Modular & Movable Shielding Solutions – The Medical Radiation Shielding market is witnessing an increasing preference for mobile and modular radiation barriers, allowing greater flexibility in healthcare settings and reducing infrastructure costs

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Competitive Landscape

The competitive landscape of the Medical Radiation Shielding market is characterized by the the presence of several key players competing through product innovation, strategic partnerships, and geographical expansion. Companies such as Amray Group, ETS-Lindgren, Gaven Industries, MarShield, MAVIG GmbH, NELCO, Nuclear Shields B.V., Radiation Protection Products, Inc., VacuTec Meßtechnik GmbH, and Veritas Medical Solutions lead the industry by offering advanced shielding solutions for radiation protection in healthcare settings. Medical Radiation Shielding Market participants focus on developing lead-based and lead-free shielding materials, including composite and polymer-based alternatives, to enhance safety while addressing environmental concerns. Strategic acquisitions, such as Trivitron Healthcare’s purchase of The Kennedy Company, have strengthened manufacturing capabilities, while FDA approvals, such as Radiaction Medical Ltd.’s radiation protection system clearance, have facilitated market entry and expansion. Collaborations, like ESCO Technologies’ partnership with IMRIS for MRI shielding at Boston Children’s Hospital, highlight the growing demand for integrated shielding solutions. The Medical Radiation Shielding market is further driven by increasing cancer treatment centers, advancements in radiotherapy, and the rising adoption of theranostic approaches, which blend imaging and therapeutic applications. With technological advancements and regulatory approvals shaping the industry, competition remains intense, prompting companies to invest in research, innovation, and global Medical Radiation Shielding market penetration.

The key players in the global Medical Radiation Shielding market include - NELCO, MAVIG GmbH, Radiation Protection Products, Inc., Veritas Medical Solutions, VacuTec Meßtechnik GmbH, Nuclear Shields B.V., ETS-Lindgren, Gaven Industries, MarShield, Amray Group among others.

Latest Announcements in Medical Radiation Shielding Market

• October 2024: Researchers at the London Health Sciences Centre Research Institute (LHSCRI) became the first in Canada to treat a patient with neuroendocrine tumors (NETs) using actinium-225 DOTATATE. This innovative therapy, classified under theranostics, combines advanced diagnostic imaging with radioisotopes to precisely locate and eliminate tumors through targeted radioactive energy
• April 2024: MarShield introduced Plasti-Shield, a neutron shielding material composed of boron-filled polyethylene. Designed for cost efficiency and lightweight application, this solution effectively absorbs and attenuates neutron radiation. It is widely utilized across various industries, including healthcare, cancer treatment centers, diagnostic facilities, and hospitals
• March 2024: WestCan Proton Therapy Inc. announced its plans to open Canada’s first proton therapy treatment center, the Ben Stelter Centre, in Edmonton. With an investment of approximately USD 90.5 million (CAD 120 million), the Centre for Proton Therapy and Neuroscience will provide cutting-edge radiation therapies for cancer patients in Canada
• February 2024: The Montérégie Integrated Cancer Center, affiliated with Charles-LeMoyne Hospital in Quebec, became one of the first institutions in Canada to offer cancer treatment using Accuray's Radixact radiation therapy system. A second Radixact system was scheduled for installation at the center later in 2024
• February 2023: SDS Specialist Door Solutions introduced Shieldoor, a lead-lined X-ray door designed to enhance protection in hospitals and radiology facilities, addressing the demands of high-radiation environments
• March 2022: Radiaction Medical Ltd. secured FDA clearance for its groundbreaking radiation protection system. This approval facilitated the company’s entry into the U.S. market, marking a significant advancement in radiation protection for healthcare professionals
• March 2022: Trivitron Healthcare expanded its U.S. operations by acquiring The Kennedy Company, a manufacturer of acoustic barrier products and radiation shielding materials. This strategic acquisition strengthened Trivitron’s manufacturing presence in the U.S. and laid the foundation for a high-tech facility in Scottsboro, Alabama
• September 2022: ESCO Technologies partnered with IMRIS, Deerfield Imaging, to establish an advanced MRI facility at Boston Children’s Hospital in Massachusetts. The newly inaugurated Hale Family building integrates IMRIS’ cutting-edge intraoperative MRI (iMRI) technology, enabling real-time imaging during surgical procedures

Medical Radiation Shielding Market Segments Covered in the report:

Product Type

• X-ray Shields
  • Lead Sheets and Plates
  • Lead Bricks
  • Lead Curtains
  • Lead Glass
  • Lead Aprons
• MRI Shields
  • RF Shielding Systems
  • Magnetic Shielding Systems
• Gamma Shields
  • Gamma Camera Shields
  • Positron Emission Tomography (PET) Shields
• Neutron Shields
  • Neutron Absorbers
  • Neutron Reflectors

Material

• Lead-based Shielding
• Non-lead Shielding
• Hybrid Shielding

Application

• Diagnostics
  • Radiography (X-ray)
  • Computed Tomography (CT)
  • Fluoroscopy
  • Mammography
  • Dental Imaging
• Therapeutics
  • Radiotherapy
  • Brachytherapy
  • Proton Therapy
• Nuclear Medicine
  • SPECT (Single Photon Emission Computed Tomography)
  • Positron Emission Tomography (PET)

End-use

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Radiotherapy Centers
• Research Laboratories & Academic Institutions
• Other End-use

Medical Radiation Shielding Market Regions and Countries:

North America

• U.S.
• Canada
• Mexico

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Nordic Countries
• Benelux Union
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America

The Middle-East and Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of Middle-East Africa